Literature DB >> 27980283

Pure Cusp Tear of Trifecta Bioprosthesis 2 Years after Aortic Valve Replacement.

Masaki Hamamoto1, Taira Kobayashi1, Masamichi Ozawa1, Kosuke Yoshimura1.   

Abstract

Trifecta is a stented bioprosthetic heart valve with a bovine pericardial sheet externally mounted on a titanium stent. This valve is applied only for aortic valve replacement (AVR), providing excellent hemodynamics and extremely low incidence of structural valve deterioration (SVD). A 76-year-old woman presented with dyspnea on effort 24 months after AVR with a 21-mm Trifecta valve. Echocardiography revealed severe aortic regurgitation with prolapse of a cusp of Trifecta valve, which suggested that she developed acute heart failure due to early SVD. In the operation, Trifecta valve had a cusp tear near the commissure with circumferential fibrous pannus ingrowth only at the inflow side. There was neither calcification nor infection. The Trifecta valve was successfully replaced with a new porcine bioprosthesis.

Entities:  

Keywords:  Trifecta; aortic valve replacement; pericardial bioprosthesis; structural valve deterioration

Mesh:

Year:  2016        PMID: 27980283      PMCID: PMC5483864          DOI: 10.5761/atcs.cr.16-00183

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  10 in total

1.  Computer modelling of bioprosthetic heart valves.

Authors:  G W Christie
Journal:  Eur J Cardiothorac Surg       Date:  1992       Impact factor: 4.191

Review 2.  The evolution of bioprosthetic heart valve design and its impact on durability.

Authors:  I Vesely
Journal:  Cardiovasc Pathol       Date:  2003 Sep-Oct       Impact factor: 2.185

3.  Early structural valve deterioration of the Trifecta aortic valve biological prosthesis: a word of caution.

Authors:  Pankaj Saxena; Kevin L Greason; Hartzell V Schaff
Journal:  J Thorac Cardiovasc Surg       Date:  2013-09-14       Impact factor: 5.209

4.  Tears in bioprosthetic heart valve leaflets without calcific degeneration.

Authors:  F Haziza; G Papouin; B Barratt-Boyes; G Christie; R Whitlock
Journal:  J Heart Valve Dis       Date:  1996-01

5.  Leaflet tear in a Trifecta aortic bioprosthesis 34 months after implantation.

Authors:  Miguel Piñón; Darío Durán; Pablo Pazos; Gonzalo Pradas
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-11-16

6.  Early failures of Trifecta aortic bioprosthesis.

Authors:  Salvatore Campisi; Lionel Camilleri; Andrea Innorta; Kasra Azarnoush
Journal:  J Thorac Cardiovasc Surg       Date:  2014-03-20       Impact factor: 5.209

7.  St. Jude Medical Trifecta™ aortic valve perioperative performance in 200 patients.

Authors:  Eduard Permanyer; Arnaldo-Javier Estigarribia; Alejandro Ysasi; Enrique Herrero; Omar Semper; Rafael Llorens
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-03

8.  The St Jude Medical Trifecta aortic pericardial valve: results from a global, multicenter, prospective clinical study.

Authors:  Joseph E Bavaria; Nimesh D Desai; Anson Cheung; Michael R Petracek; Mark A Groh; Michael A Borger; Hartzell V Schaff
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03-07       Impact factor: 5.209

Review 9.  Bioprosthetic heart valves: modes of failure.

Authors:  Raheela Fareed Siddiqui; Johnathan Rajiv Abraham; Jagdish Butany
Journal:  Histopathology       Date:  2009-08       Impact factor: 5.087

10.  Hemodynamic performance of Trifecta: single-center experience of 400 patients.

Authors:  Amit Modi; Mindaugas Budra; Szabolcs Miskolczi; Theodore Velissaris; Markku Kaarne; Clifford W Barlow; Steven A Livesey; Sunil K Ohri; Geoffrey M Tsang
Journal:  Asian Cardiovasc Thorac Ann       Date:  2014-05-13
  10 in total
  7 in total

Review 1.  Prosthetic cardiac valves: history and review of cardiac prostheses clinically available in Japan.

Authors:  Eiki Tayama; Kosuke Saku; Tomoyuki Anegawa; Atsunobu Oryoji; Shinya Negoto
Journal:  Surg Today       Date:  2021-08-25       Impact factor: 2.549

2.  Mid-term clinical and health-related quality of life outcomes for the Trifecta bioprosthesis.

Authors:  Biswarup Purkayastha; Md Wasim Khan; Atanu Saha; Debasis Das; Lalit Kapoor; Mrinalendu Das; Pradeep Narayan
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-04-27

3.  Impact of postoperative patient-prosthesis mismatch as a risk factor for early structural valve deterioration after aortic valve replacement with Trifecta bioprosthesis.

Authors:  Tatsuto Wakami; Shigeki Koizumi; Tadaaki Koyama
Journal:  J Cardiothorac Surg       Date:  2022-07-08       Impact factor: 1.522

4.  Early surgical aortic bioprosthesis failure caused by cusp tear: A word of caution.

Authors:  Thibault Schaeffer; Denis Berdajs; Oliver Reuthebuch
Journal:  Clin Case Rep       Date:  2020-11-28

5.  Modes of failure of Trifecta aortic valve prosthesis.

Authors:  Pietro Giorgio Malvindi; Hassan Kattach; Suvitesh Luthra; Sunil Ohri
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-07-09

6.  Trifecta versus Perimount Magna Ease aortic valves: Failure mechanisms.

Authors:  Ryo Suzuki; Toshiro Ito; Masato Suzuki; Shunsuke Ohori; Ryo Takayanagi; Shiro Miura
Journal:  Asian Cardiovasc Thorac Ann       Date:  2022-05-22

7.  Structural valve deterioration of a pericardial bioprosthesis.

Authors:  Hassan Kattach; Clifford W Barlow; Sunil K Ohri
Journal:  JTCVS Open       Date:  2021-12-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.